Revolution of 3d printing in pharmaceuticals: innovations, applications, and future perspectives

3D printing, or additive manufacturing, is transforming the pharmaceutical industry by enabling the precise fabrication of complex drug formulations, personalized dosages, and advanced drug delivery systems. Initially utilized in aerospace and automotive industries, 3D printing has rapidly been adopted in pharmaceuticals, offering new opportunities for customized medicine, rapid prototyping, and on-demand drug manufacturing. This review explores the current advancements in 3D printing technologies, such as Fused Deposition Modeling (FDM), Stereolithography (SLA), Selective Laser Sintering (SLS), Inkjet Printing, and Extrusion-Based Printing. These technologies have shown significant potential in creating personalized medication, developing complex drug delivery systems, and addressing pediatric and geriatric populations' unique needs. Despite these advancements, challenges still need to be addressed, including regulatory hurdles, technical limitations, scalability issues, and intellectual property concerns. Future directions include integrating 3D printing with digital health technologies for real-time patient monitoring and personalized treatment, developing advanced materials and printing technologies, and evolving regulatory frameworks to accommodate the growing use of 3D printing in pharmaceuticals. Collaborative research and development are crucial to overcoming these challenges and realizing the full potential of 3D printing in revolutionizing drug manufacturing and delivery, particularly in improving global accessibility to essential medicines.